Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1118135.RAbouQcQdgAXXMYgheWTNEV1zh_RO0IYLAlpU4BCDvvwQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1118135.RAbouQcQdgAXXMYgheWTNEV1zh_RO0IYLAlpU4BCDvvwQ130_assertion type Assertion NP1118135.RAbouQcQdgAXXMYgheWTNEV1zh_RO0IYLAlpU4BCDvvwQ130_head.
- NP1118135.RAbouQcQdgAXXMYgheWTNEV1zh_RO0IYLAlpU4BCDvvwQ130_assertion wasGeneratedBy ECO_0000203 NP1118135.RAbouQcQdgAXXMYgheWTNEV1zh_RO0IYLAlpU4BCDvvwQ130_provenance.
- NP1118135.RAbouQcQdgAXXMYgheWTNEV1zh_RO0IYLAlpU4BCDvvwQ130_assertion wasDerivedFrom befree-2016 NP1118135.RAbouQcQdgAXXMYgheWTNEV1zh_RO0IYLAlpU4BCDvvwQ130_provenance.
- NP1118135.RAbouQcQdgAXXMYgheWTNEV1zh_RO0IYLAlpU4BCDvvwQ130_assertion SIO_000772 24116031 NP1118135.RAbouQcQdgAXXMYgheWTNEV1zh_RO0IYLAlpU4BCDvvwQ130_provenance.
- NP1118135.RAbouQcQdgAXXMYgheWTNEV1zh_RO0IYLAlpU4BCDvvwQ130_assertion evidence source_evidence_literature NP1118135.RAbouQcQdgAXXMYgheWTNEV1zh_RO0IYLAlpU4BCDvvwQ130_provenance.
- NP1118135.RAbouQcQdgAXXMYgheWTNEV1zh_RO0IYLAlpU4BCDvvwQ130_assertion description "[In search of a sensitizing strategy to overcome this relative ATRA resistance, we investigated the potency of the HDAC class-I selective inhibitor entinostat in AML cell lines Kasumi-1 and HL-60 and primary AML blasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1118135.RAbouQcQdgAXXMYgheWTNEV1zh_RO0IYLAlpU4BCDvvwQ130_provenance.